ZyVersa Therapeutics Reports Third Quarter 2025 Financial Results

GlobeNewswire
2025.11.19 22:03
portai
I'm PortAI, I can summarize articles.

WESTON, Fla., Nov. 19, 2025 ( GLOBE NEWSWIRE ) -- ZyVersa Therapeutics, Inc. ( OTCQB: ZVSA, or "ZyVersa" ) , a clinical-stage specialty biopharmaceutical company developing first-in-class drugs for treatment of patients with renal and inflammatory diseases who have unmet medical needs, reports ...

Source: GlobeNewswire The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2026 Longbridge｜Disclaimer